Genomic deletions in MSH2 or MLH1 are a
โ
C.F. Taylor; R.S. Charlton; J. Burn; E. Sheridan; G.R. Taylor
๐
Article
๐
2003
๐
John Wiley and Sons
๐
English
โ 179 KB
๐ 2 views
Gene dosage abnormalities account for a significant proportion of the mutations in genes tested in DNA diagnostic laboratories. Detection of these changes has proved a challenge as the methods available to date are time consuming or unreliable. The multiplex ligation-dependent probe assay (MLPA) is